Selected research
Industry Research
circRNA Technology Industry Research Report 2026
Market perspective
The global circRNA Technology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the circRNA Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the circRNA Technology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the circRNA Technology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of circRNA Technology include Orna Therapeutics, Sail Biomedicines, Therorna Inc., CirCode Bio, Abogen Biosciences, SuZhou CureMed Biomedical Technology Co, Guangzhou Geneseed Biotech. Co., Ltd. and Rznomics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global circRNA Technology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to circRNA Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
circRNA Technology Market by Company
Orna Therapeutics
Sail Biomedicines
Therorna Inc.
CirCode Bio
Abogen Biosciences
SuZhou CureMed Biomedical Technology Co
Guangzhou Geneseed Biotech. Co., Ltd.
Rznomics
circRNA Technology Segment by Type
circRNA Synthesis
Drug Delivery
Other
circRNA Technology Segment by Application
Gene Therapy
Drug Delivery
Vaccine Delivery
circRNA Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global circRNA Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of circRNA Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of circRNA Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of circRNA Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- circRNA Synthesis
- Drug Delivery
- Other
Applications
- Gene Therapy
- Drug Delivery
- Vaccine Delivery
Companies covered
- Orna Therapeutics
- Sail Biomedicines
- Therorna Inc.
- CirCode Bio
- Abogen Biosciences
- SuZhou CureMed Biomedical Technology Co
- Guangzhou Geneseed Biotech. Co., Ltd.
- Rznomics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 circRNA Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 circRNA Synthesis
- 2.2.3 Drug Delivery
- 2.2.4 Other
- 2.3 circRNA Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Gene Therapy
- 2.3.3 Drug Delivery
- 2.3.4 Vaccine Delivery
- 2.4 Assumptions and Limitations
3 circRNA Technology Breakdown Data by Type
- 3.1 Global circRNA Technology Historic Market Size by Type (2021-2026)
- 3.2 Global circRNA Technology Forecasted Market Size by Type (2027-2032)
4 circRNA Technology Breakdown Data by Application
- 4.1 Global circRNA Technology Historic Market Size by Application (2021-2026)
- 4.2 Global circRNA Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global circRNA Technology Market Perspective (2021-2032)
- 5.2 Global circRNA Technology Growth Trends by Region
- 5.2.1 Global circRNA Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 circRNA Technology Historic Market Size by Region (2021-2026)
- 5.2.3 circRNA Technology Forecasted Market Size by Region (2027-2032)
- 5.3 circRNA Technology Market Dynamics
- 5.3.1 circRNA Technology Industry Trends
- 5.3.2 circRNA Technology Market Drivers
- 5.3.3 circRNA Technology Market Challenges
- 5.3.4 circRNA Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top circRNA Technology Players by Revenue
- 6.1.1 Global Top circRNA Technology Players by Revenue (2021-2026)
- 6.1.2 Global circRNA Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global circRNA Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of circRNA Technology Head Office and Area Served
- 6.4 Global circRNA Technology Players, Product Type & Application
- 6.5 Global circRNA Technology Manufacturers Established Date
- 6.6 Global circRNA Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America circRNA Technology Market Size (2021-2032)
- 7.2 North America circRNA Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America circRNA Technology Market Size by Country (2021-2026)
- 7.4 North America circRNA Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe circRNA Technology Market Size (2021-2032)
- 8.2 Europe circRNA Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe circRNA Technology Market Size by Country (2021-2026)
- 8.4 Europe circRNA Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific circRNA Technology Market Size (2021-2032)
- 9.2 Asia-Pacific circRNA Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific circRNA Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific circRNA Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America circRNA Technology Market Size (2021-2032)
- 10.2 South America circRNA Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America circRNA Technology Market Size by Country (2021-2026)
- 10.4 South America circRNA Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa circRNA Technology Market Size (2021-2032)
- 11.2 Middle East & Africa circRNA Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa circRNA Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa circRNA Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Orna Therapeutics
- 12.1.1 Orna Therapeutics Company Information
- 12.1.2 Orna Therapeutics Business Overview
- 12.1.3 Orna Therapeutics Revenue in circRNA Technology Business (2021-2026)
- 12.1.4 Orna Therapeutics circRNA Technology Product Portfolio
- 12.1.5 Orna Therapeutics Recent Developments
- 12.2 Sail Biomedicines
- 12.2.1 Sail Biomedicines Company Information
- 12.2.2 Sail Biomedicines Business Overview
- 12.2.3 Sail Biomedicines Revenue in circRNA Technology Business (2021-2026)
- 12.2.4 Sail Biomedicines circRNA Technology Product Portfolio
- 12.2.5 Sail Biomedicines Recent Developments
- 12.3 Therorna Inc.
- 12.3.1 Therorna Inc. Company Information
- 12.3.2 Therorna Inc. Business Overview
- 12.3.3 Therorna Inc. Revenue in circRNA Technology Business (2021-2026)
- 12.3.4 Therorna Inc. circRNA Technology Product Portfolio
- 12.3.5 Therorna Inc. Recent Developments
- 12.4 CirCode Bio
- 12.4.1 CirCode Bio Company Information
- 12.4.2 CirCode Bio Business Overview
- 12.4.3 CirCode Bio Revenue in circRNA Technology Business (2021-2026)
- 12.4.4 CirCode Bio circRNA Technology Product Portfolio
- 12.4.5 CirCode Bio Recent Developments
- 12.5 Abogen Biosciences
- 12.5.1 Abogen Biosciences Company Information
- 12.5.2 Abogen Biosciences Business Overview
- 12.5.3 Abogen Biosciences Revenue in circRNA Technology Business (2021-2026)
- 12.5.4 Abogen Biosciences circRNA Technology Product Portfolio
- 12.5.5 Abogen Biosciences Recent Developments
- 12.6 SuZhou CureMed Biomedical Technology Co
- 12.6.1 SuZhou CureMed Biomedical Technology Co Company Information
- 12.6.2 SuZhou CureMed Biomedical Technology Co Business Overview
- 12.6.3 SuZhou CureMed Biomedical Technology Co Revenue in circRNA Technology Business (2021-2026)
- 12.6.4 SuZhou CureMed Biomedical Technology Co circRNA Technology Product Portfolio
- 12.6.5 SuZhou CureMed Biomedical Technology Co Recent Developments
- 12.7 Guangzhou Geneseed Biotech. Co., Ltd.
- 12.7.1 Guangzhou Geneseed Biotech. Co., Ltd. Company Information
- 12.7.2 Guangzhou Geneseed Biotech. Co., Ltd. Business Overview
- 12.7.3 Guangzhou Geneseed Biotech. Co., Ltd. Revenue in circRNA Technology Business (2021-2026)
- 12.7.4 Guangzhou Geneseed Biotech. Co., Ltd. circRNA Technology Product Portfolio
- 12.7.5 Guangzhou Geneseed Biotech. Co., Ltd. Recent Developments
- 12.8 Rznomics
- 12.8.1 Rznomics Company Information
- 12.8.2 Rznomics Business Overview
- 12.8.3 Rznomics Revenue in circRNA Technology Business (2021-2026)
- 12.8.4 Rznomics circRNA Technology Product Portfolio
- 12.8.5 Rznomics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst